Newsfeeds - Spark Newswire

2 minute read

This Psychedelics Company Is Undertaking A 1:50 Reverse Stock Split To Enter NASDAQ

Today, 3:54 AM

The psychedelics landscape changes quickly. Whether large or small, every biotech company is looking for ways to further advance their research and product & services commercialization.

MNMD

2 minute read

Preclinical Ketamine Trial Shows Positive Results For Pain Conditions Like Fibromyalgia And Arthritis

By Lara Goldstein

Today, 3:54 AM

Biotech psychedelics researcher and developer Silo Pharma Inc. (OTCQB: SILO) announced its topically-administered proprietary ketamine obtained a positive outcome in a recent preclinical study.

SILO

2 minute read

4 Penny Stocks Insiders Are Buying

By Lisa Levin

Today, 3:54 AM

When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.

ADMQ